Parkinson's disease apparently doubles melanoma risk

Parkinson’s disease is a brain confusion that probably triggers tremors beside with difficulty in movement. It probably affects regarding one million people in the United States. An investigation of several studies now suggests that Parkinson’s disease patients face superior chances of developing melanoma, a deadly skin cancer.

This investigation analyzed 12 studies conduct from 1965 and 2010 that inspect the possible link between Parkinson’s disease and melanoma. Majority of the studies so they say had less than 10 cases with both conditions. It was experiential that men with Parkinson’s disease may be twice as possible as those without Parkinson’s to have melanoma.

“Parkinson’s disease patients in common have a lower risk for cancer, smoking-related cancers in particular, but they may have a superior risk for melanoma. One possible clarification for the link between Parkinson’s and melanoma is that the two diseases may share some heritable or environmental risk factors,” common study author Honglei Chen, MD, PhD, with the National Institute of Environmental Health Sciences. “However, our considerate of this link is very preliminary.”

Chicago among sites for foremost study on Parkinson's disease

About 1 million American people have Parkinson's disease, a progressive disorder of the central nervous system. There are treatments that can temporarily improve the symptoms, but there is not a cure. Now, a five-year study is being kick off at 18 research sites around the world, including one in Chicago, to speed up the growth of treatments to slow or stop the progression of this disease. The Parkinson's Progression Markers scheme, a study funded with $40 million from the Michael J. Fox Foundation, will be enrolling 400 recently diagnosed patients with Parkinson's and 200 people who do not have the disease.

Northwestern Medicine's Parkinson's Disease and Movement Disorders Center in Chicago hope to enroll 20 people to contribute for two years, according to the foundation. Northwestern are one of 14 research sites in the U.S., and the only one in the Midwest contribute in the study. Researchers will be seemed for the biomarkers for Parkinson's disease. "Parkinson's is a disease without a clear-cut diagnosis and without a cure," Dr. Tanya Simuni, principal examiner for the study at Northwestern and director of the Parkinson's Disease and group Disorders Center, said in a news release. "While significant strides have been made in the growth of drugs to manage the disease, hope for the prospect lies in the development of new drugs to slow or stop the progression of Parkinson's."

The four main symptoms of Parkinson's are tremor or trembling in the hands, arms, legs, jaw and face, stiffness of the limbs and trunk, slowness of group and impaired balance and coordination, according to the National Institute of Neurological Disorders and Stroke. Over time, people with Parkinson's have trouble walking, talking and responsibility simple tasks. Parkinson's typically influence people over age 50. Michael J. Fox was diagnosed with young-onset Parkinson's 19 years ago.

useful links : transport rankings

Sense of smell tests key to tackling Parkinson's diseases

Losing your sense of smell could be an premature sign of Parkinson's disease, scientists have warned. The growth of smell tests could help doctors diagnose the condition much earlier - vastly improving sufferers' lives. At present, many are given drugs far too late because by the time the familiar shaking symptoms of Parkinson's appear, action makes little difference.

A test is a step closer after scientists discovered that sense of smell is reduced by the presence in the brain of a exacting protein linked to the development of Parkinson's. About 120,000 Britons suffer from Parkinson's, a degenerative disorder of the central nervous system that influence the control of motor skills, speech, mood and behavioural problems and cognitive functions. There's no cure.

In the study, Dr Silke Nuber from Germany's Tubingen University found that mice with higher levels of a protein known as human alpha-synuclein had a poor intelligence of smell - as well as showing signs of Parkinson's. Dr Kieran Breen, director of research at charity Parkinson's UK, said he supposed a new test could be available within five years.

useful links: transport rankings